NUCALA® Special Drug Use Investigation (EGPA, Long-term)

Clinical trial NCT03557060 · COMPLETED

Trial details

NCT number: NCT03557060
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Churg-Strauss Syndrome Eosinophilic Granulomatosis With Polyangiitis

Start date: 2018-06-25
Primary completion: 2025-07-30
Enrollment: 4115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.